• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Ocusoft?









DON'T DO IT. I am a current rep and have been here for 5 months. Search the company on linkedin and check the tenure of the sales reps. Every rep I know (myself included) are looking/interviewing for other positions. All this position will do to your resume is make you look like a "job hopper" and try to explain why you were only there for a year or less. Micro management doesn't begin to explain it. Constant reports- one you have to do every weekend. Trust me. I took this position to get pharma experience after b2b. It is not worth it. $45-65k is base for reps and bonus is a joke.